Highlights of the Program

2 days business program:

Learn from real-world case studies by industry leaders.

SHOWCASING INNOVATION:

Discover the latest technology and techniques from across the industry.

leaders talk:

Hear from top-level experts about how to stay ahead in a fast-changing industry.

MULTIPLE STREAMS:

A business program that is multi-disciplinary, giving you a broad view of the industry.

SMART TECHNOLOGIES:

Explore the latest smart and AI-driven solutions, and see how they can be used in your business.

roundtable discussion:

Join talks with industry peers. Share ideas, make connections, and find new partners.

Program

Day 1 :
WEDNESDAY, APRIL 29, 2026
08:30 - 09:30
REGISTRATION AND MORNING REFRESHMENTS
09:30 - 09:40
OPENING ADDRESS
09:40 - 10:10
RESERVED PRESENTATION
10:10 - 10:40
SPEED NETWORKING SESSION
  • Exchange business cards and get connected in short one-to-one meetings
  • Start the conversation to arrange a more formal meeting later on in the conference
  • Share your professional background and discuss your biggest business issues – don't forget your business cards
10:40 - 11:00
MORNING COFFEE BREAK IN THE EXHIBIT AREA
11:00 - 11:30
PANEL DISCUSSION ON METABOLIC MEDICINE
11:30 - 11:55
OPTIMIZING GLP-1 AGONIST THERAPY THROUGH METHYLATION PATHWAY ASSESSMENT
Charles Sailey
Molecular Testing Labs

Charles Sailey

Molecular Testing Labs

  • Introducing gene-guided GLP-1 optimization using methylation variants like MTHFR and COMT
  • Enhancing metabolic outcomes by correcting inefficiencies in one-carbon nutrient pathways
  • Demonstrating improved GLP-1 efficacy and detox response through precision supplementation
11:55 - 12:00
Q&A SESSION ON PRECISION GENETICS AND GLP-1 RESPONSE
12:00 - 13:30
NETWORKING LUNCH AND VISITING THE OBESITY MEDICINE EXHIBITION
13:30 - 13:55
THE MIND/BODY PROBLEM – METABOLIC SYNDROME AND COGNITIVE DECLINE
Steve Winshel
FULLFILL

Steve Winshel

FULLFILL

  • Clarifying the strong links between metabolic dysfunction and cognitive impairments
  • Highlighting complications due to the late detection of cognitive decline in patients
  • Showcasing innovative early detection tools to prevent irreversible brain changes
  • Integrating mind-body approaches to address both metabolic and cognitive issues
13:55 - 14:00
Q&A SESSION ON LINKING METABOLISM AND BRAIN HEALTH
14:00 - 14:25
IMPROVING ARRHYTHMIA MANAGEMENT THROUGH EARLY DETECTION IN COMORBID PATIENTS (T2DM, CKD, CAD, COPD)
Joe Valderas
iRhythm Technologies, Inc.

Joe Valderas

iRhythm Technologies, Inc.

  • Leveraging EMR-based AI to identify high-risk comorbid patients earlier and reduce ER visits
  • Highlighting limits of symptom-led screening, with 18% rhythm correlation in 1.1M patients
  • Quantifying diagnostic overshadowing, with only one in four escalated to cardiac monitoring
14:25 - 14:30
Q&A SESSION ON EARLY ARRHYTHMIA DETECTION IN COMORBIDITY
14:30 - 15:00
AFTERNOON COFFEE BREAK IN THE EXHIBIT AREA
15:00 - 15:25
UNLOCKING NATURAL WEIGHT-REGULATING BIOLOGY THROUGH LEPTIN SENSITIZATION
Teo Uysal
ERX Pharmaceuticals

Teo Uysal

ERX Pharmaceuticals

  • Delving into leptin's pivotal role in weight regulation and obesity treatment
  • Uncovering unique biological mechanisms for enhanced efficacy and muscle preservation
  • Presenting promising initial findings from a Phase 1 study of a novel leptin sensitizer
15:25 - 15:30
Q&A SESSION ON LEPTIN SENSITIZATION IN OBESITY TREATMENT
15:30 - 15:55
ENABLING DEVICE SOLUTIONS FOR UNMET NEEDS IN BIOTHERAPIES
Asmita Khanolkar
SMC<sup>®</sup> Ltd.

Asmita Khanolkar

SMC® Ltd.

  • Highlighting novel methods for drug-device-delivery optimization and assessment
  • Introducing an autoinjector simulator to evaluate pharmacokinetics and dynamics
  • Accelerating early evaluation and speed to clinics for biologics with unique needs
15:55 - 16:00
Q&A SESSION ON ENABLING DEVICE SOLUTIONS IN BIOTHERAPIES
16:00 - 16:30
RESERVED PRESENTATION
16:30 - 17:30
NETWORKING DRINKS RECEPTION
Day 2 :
THURSDAY, APRIL 30, 2026
09:00 - 09:30
MORNING REFRESHMENTS
09:30 - 09:40
OPENING ADDRESS
09:40 - 10:05
ENSURING ACCESS AND SUPPORT IN OBESITY CARE
Sansei Fowler
CVS Health

Sansei Fowler

CVS Health

  • Enhancing patient access to obesity treatments through optimal payer coverage strategies
  • Coordinating care models for GLP-1 therapy for comprehensive support to improved outcomes
  • Forecasting future trends in obesity treatment by analyzing drug pipelines and the role of PBMs in care
10:05 - 10:10
Q&A SESSION ON THE ACCESS AND SUPPORT IN OBESITY TREATMENT
10:10 - 10:35
NA-931: AN ORAL QUADRUPLE RECEPTOR AGONIST FOR WEIGHT LOSS WITHOUT MUSCLE LOSS
Lloyd Tran
Biomed Industries, Inc.

Lloyd Tran

Biomed Industries, Inc.

  • Describing the mechanism of action of this oral quadruple receptor agonist
  • Summarizing topline Phase 1 and Phase 2 clinical trial results on the safety and efficacy of NA-931
  • Reporting significant weight loss with no muscle loss or major GI-related adverse events
10:35 - 10:40
Q&A SESSION ON NA-931 AND ADVANCES IN WEIGHT MANAGEMENT
10:40 - 11:00
MORNING COFFEE BREAK IN THE EXHIBIT AREA
11:00 - 11:25
STX-001:A NOVEL ORAL THERAPEUTIC FOR OBESITY
Ilan Zipkin
Supercede Therapeutics

Ilan Zipkin

Supercede Therapeutics

  • Introducing STX-001, an oral activin receptor II inhibitor for selective fat loss
  • Enabling combination with GLP-1 to enhance fat loss while sustaining lean mass outcomes
  • Revealing preclinical STX-001 data in DIO mice and GLP-1 combination experiments
11:25 - 11:30
Q&A SESSION ON STX-001 AND SELECTIVE FAT LOSS IN OBESITY
11:30 - 11:55
EXPLORING INNOVATIVE TECHNOLOGIES IN THE FIGHT AGAINST OBESITY
Ashley Zehnder
Fauna Bio

Ashley Zehnder

Fauna Bio

  • Discussing rising global obesity rates and the urgent need for innovative solutions
  • Examining the role of muscle-preserving agents in improving metabolic health during weight loss
  • Highlighting recent technological and biomedical advancements in obesity treatment strategies
11:55 - 12:00
Q&A SESSION ON USING MUSCLE PRESERVATION FOR OBESITY TREATMENTS
12:00 - 12:25
DATA-DRIVEN METABOLIC RESET - A 90 DAY PROGRAM FOR LIFELONG WELLNESS
Harris Masket
Jyzen

Harris Masket

Jyzen

  • Personalizing a 90-day metabolic reset with advanced labs, metabolic testing, and wearables
  • Optimizing therapeutics with customized peptides, supplements, nutrition, and training plans
  • Measuring and sharing program data from labs and wearables that demonstrate metabolic gains
12:25 - 12:30
Q&A SESSION ON DATA-DRIVEN METABOLIC RESET
12:30 - 12:45
FEEDBACK & RAFFLE DRAW
12:45 - 14:00
NETWORKING LUNCH

Become a Speaker & Join the Conversation

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.